Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(21):1594-1595; doi:10.1093/jnci/94.21.1594
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gius, D.
Right arrow Articles by Coleman, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gius, D.
Right arrow Articles by Coleman, C. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 21, 1594-1595, November 6, 2002
© 2002 Oxford University Press

EDITORIAL

Treatment of Nasopharyngeal Cancer: Raising the "Barr"

David Gius, C. Norman Coleman

Affiliation of authors: D. Gius, C. N. Coleman, Radiation Oncology Branch, Center for Cancer Research, Radiation Oncology Sciences Program, National Cancer Institute, Bethesda, MD.

Correspondence to: David Gius, M.D., Ph.D., National Cancer Institute, DCRT, Bldg. 10, Rm. B3B69, MSC 1002, Bethesda, MD 20892–1002 (e-mail: giusd@mail.nih.gov).

The first 10% of the full text of this article appears below.

Nasopharyngeal carcinoma (NPC) is distinguished from other head and neck malignancies by virtue of its unique clinical and pathologic characteristics. NPC is an epithelial tumor with a distinct geographic distribution that is uncommon in Europe and North America but common in southern China (1). Multiple factors play a role in the pathogenesis of NPC, including genetic predisposition, environmental factors, and Epstein-Barr virus (EBV) infection (2–4).

Histopathologically, NPC is separated into the following three categories by the World Health Organization (WHO) (1,5): 1) keratinizing squamous-cell carcinoma similar to other head and neck tumors (type I); 2) nonkeratinizing epidermoid carcinoma (type II); and 3) undifferentiated carcinomas referred to as . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?